First principle: one switch, then two hormones
The bipotential gonad defaults to ovary unless SRY diverts it to testis. A testis then does two independent jobs:
The two testicular outputs are separable, and that separability is the clinical reasoning:
- AMH (Sertoli) removes the female ducts;
- testosterone → DHT (Leydig) builds male internal and external structures.
Discriminators: reason from the mismatch
Because chromosomes, gonad and phenotype are built by different steps, a mismatch localises the defect:
| Karyotype | Gonad | Uterus? | Reason |
|---|---|---|---|
| 46,XY, androgen receptor defect (CAIS) | testes | absent (AMH worked) | end‑organ can't read testosterone → female phenotype |
| 46,XY, gonadal dysgenesis (Swyer) | streak | present (no AMH) | testis never formed → no AMH, no androgen |
| 46,XX, 21‑OH CAH | ovaries | present | adrenal androgen virilises externally |
Red flags 🚩
- A 46,XY karyotype with dysgenetic (streak) gonads carries gonadoblastoma/malignancy risk → gonadectomy is advised.
Pitfalls
- Equating "Y chromosome" with "male genitalia." Phenotype depends on the whole chain (AMH + androgen + receptor + 5α‑reductase), any link of which can fail.
Pearls
- 🎯 Sertoli → AMH; Leydig → testosterone → DHT. Uterus present vs absent tells you whether AMH was ever active — the fastest split between Swyer and CAIS.
Next → If the Müllerian ducts persist, what exactly do they build — and what stays independent? (Concept 3).